Abstract:INTRODUCTION:Hepatocellular carcinoma is currently the second leading cause of cancer-related deaths worldwide with an increasing incidence.OBJECTIVE:The objective of this study is to investigate the effect of vascular endothelial growth factor small interfering RNA (VEGF-siRNA) on rabbit VX2 carcinoma cell viability in vitro and the effect of transarterial embolization (TAE)-mediated VEGF-siRNA delivery on the growth of rabbit VX2 liver-transplanted model in vivo.METHODS:Quantitative reverse transcription polymerase chain reaction, enzyme-linked immunosorbent assay, and Western blot technologies were used to detect the expression level of VEGF. TAE and computed tomography scan were used to deliver the VEGF-siRNA and detect the tumor volume in vivo, respectively. Microvessel density was detected by immunohistochemistry with CD34 antibody. A biochemical autoanalyzer was used to evaluate the hepatic and renal toxicity.RESULTS:The designed VEGF-siRNAs could effectively decrease the expression levels of VEGF mRNA and protein in vitro and in vivo. In vitro, the viability of rabbit VX2 carcinoma cells was reduced by 38.5%±7.3% (VEGF-siRNA no 1) and 30.0%±5.8% (VEGF-siRNA no 3) at 48 hours after transfection. Moreover, in rabbit VX2 liver-transplanted model, the growth ratios of tumors at 28 days after TAE-mediated siRNA delivery were 155.18%±19.42% in the control group, 79.67%±19.63% in the low-dose group, and 36.09%±15.73% in the high-dose group, with significant differences among these three groups. Microvessel density dropped to 34.22±4.01 and 22.63±4.07 in the low-dose group and high-dose group, respectively, compared with the control group (57.88±5.67), with significant differences among these three groups. Furthermore, inoculation of VX2 tumor into the liver itself at later stage induced significant increase in alanine aminotransferase and aspartate aminotransferase, indicating an obvious damage of liver functions, while treatment of VX2 tumor via TAE-mediated VEGF-siRNA had no toxicity to the livers and kidneys of rabbits, and VEGF-siRNA had the ability to protect liver damage induced by tumor growth.CONCLUSION:This is the first study to demonstrate that targeting VEGF via TAE-mediated siRNA delivery may become a powerful new option for effective treatment of hepatocellular carcinoma in the clinic.

Proliferative capability of remnant hepatic VX2 tumor in rats after treatment with radio frequency ablation

Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer after Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model

[Hepatic VX2 Tumor in Rabbits: Treated with Radio Frequency Ablation and Evaluated with Enhanced CT].

The therapeutic effect of low frequency ultrasound mediated microbubbles destruction on rabbit VX2 orthotopic hepatic tumors

VX2 carcinoma in rabbits after radiofrequency ablation: findings of CT and histupathology

Angiogenesis in Residual Cancer and Roles of HIF-1α, VEGF, and MMP-9 in the Development of Residual Cancer after Radiofrequency Ablation and Surgical Resection in Rabbits with Liver Cancer.

Microwave coagulation/ablation in combination with sorafenib suppresses the overgrowth of residual tumor in VX2 liver tumor model.

Value of 18F-FDG PET/MR Imaging in the Early Evaluation of Treatment Response following Radiofrequency Ablation of Liver Cancer in a Rabbit Model

Abstract No. 506 Image-guided Radiofrequency Hyperthermia-Enhanced Direct Chemotherapy of Hepatic Tumors: the Underlying Biomolecular Mechanisms

Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins.

Image-Guided Radiofrequency Hyperthermia (Rfh)-Enhanced Direct Chemotherapy of Hepatic Tumors: the Underlying Biomolecular Mechanisms.

The Efficiency of Sorafenib As an Adjuvant Therapy on Residual Tumor after Insufficient Thermal Ablation of Rabbit VX2 Liver Tumor

Efficacy and Safety of Percutaneous Microwave Coagulation Therapy Followed by 125I Seed Brachytherapy for VX2 Hepatic Tumors in a Rabbit Model

Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer

Effect of Radiofrequency Ablation on T Lymphocyte Subsets in Peripheral Blood of Rabbits with Renal VX-2 Carcinoma

Influence of radiofrequency ablation on vascular endothelial growth factor and fetal liver kinase 1 in transplanted liver cancer in rats

Nanosecond pulsed electric field ablates rabbit VX2 liver tumors in a non-thermal manner

Changes of IL-10 expression level in rats with Walker-256 tumor treated by radiofrequency ablation

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Efficiently Inhibits Growth of VX2 Cells and VX2 Tumor Model of Hepatocellular Carcinoma in Rabbit by Transarterial Embolization-Mediated Sirna Delivery.

The pathological changes and clinical significance of transplanted liver cancer after radiofrequency ablation in rats

MRI of VX2 carcinoma in rabbits after radiofrequency ablation:Comparison with pathological findings